News | October 04, 2024
Lilly invests US$ 4.5 billion to create advanced research and manufacturing site
The Lilly Medicine Foundry is set to drive innovation in drug production and make medicines for clinical trials
The Lilly Medicine Foundry is set to drive innovation in drug production and make medicines for clinical trials
Expansion includes a new 5-story, 136k sq. ft. multipurpose building in Sejong
Teliso-V is an investigational antibody-drug conjugate (ADC) for patients with previously treated nonsquamous non-small cell lung cancer (NSCLC) with c-Met protein overexpression
Apulki Healthcare is India's first PPP dedicated for cancer and cardiac care hospita
Showcases specialty and sustainable materials for healthcare at Medtec China 2024
She reiterated the nation's commitment to eliminating TB as a public health problem by 2030 and ensuring a healthier future for all
The raised capital enables Medix Biochemica to continue execution of inorganic growth initiatives
The partnership aims to revolutionize Artificial Intelligence in health research with innovative data platform
Agreement further expands Aptar Pharma’s leading respiratory portfolio
This Fast Track Designation will enable FDA to review MM-II in an expedited manner, is an important milestone in the development of MM-II
Subscribe To Our Newsletter & Stay Updated
